1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Key Pharma News 05 OCTOBER 2015

Key Pharma News 05 OCTOBER 2015

  • October 2015
  • -
  • Espicom Business Intelligence
  • -
  • 26 pages

Industry Trend Analysis - Zalviso's EMA Approval Is A Vital First Step For AcelRx
Industry Trend Analysis - Novartis Deal Offers XOMA Recovery Opportunity
Industry Brief - GSK Exercises Option For Inhaled Therapeutics
Industry Trend Analysis - Teva Stands To Win In Allergan/Impax Patent Battle
Industry Brief - Amgen To Acquire Dezima Pharma
Industry Brief - Novo Nordisk To Build Facility In Iran
Industry Trend Analysis - Niche Market Positioning Ahead For Sun
Industry Trend Analysis - Patent Affirmation A Boon For Shire's Development
Industry Brief - Novartis Launches Affordable Medicines Portfolio
Industry Brief - Endo Completes Par Acquisition
Industry Trend Analysis - Teva Acquisition Shows Growing Role Of Medical IT
Industry Trend Analysis - Hostility Rises As Mylan's Bid To Acquire Perrigo Sees November Endpoint
Industry Trend Analysis - Astellas/Chromocell Agreement Increases Pipeline Diversity
Industry Trend Analysis - Aspen's Domestic Business Remains Key Despite Domination Of International Sales
Industry Brief - Merck's Marizev Approved In Japan
Industry Brief - Praluent Approved For Hypercholesterolaemia In EU
Industry Brief - AbbVie's Viekirax Approved In Japan For HCV GT1
Industry Brief - Leuplin 24-Week Depot Approved In Japan
Industry Brief - VivaGel BV Gains EU Marketing Approval
Industry Brief - FDA Grants Priority Review for Ofatumumab As Relapsed CLL Maintenance Therapy
Industry Trend Analysis - Otsuka's Long-Term Oncology Position Lies Beyond Current Portfolio
Industry Brief - FDA Accepts Amgen's Kyprolis sNDA For Priority Review In Relapsed MM
Industry Trend Analysis - ITI-007's Advantage Over Competitors Will Secure Schizophrenia Market Share
Industry Brief - FDA Approves Vraylar For Bipolar I Disorder And Schizophrenia
Industry Trend Analysis - Europe Offers New Revenue Streams For Intuniv
Industry Brief - FDA Approves Tresiba For Type I/II Diabetes
Industry Brief - Allergan, Mylan Launch Paliperidone Tablets
Industry Trend Analysis - Basaglar Will Struggle To Replicate Lantus Sales
Industry Brief - Copaxone Approved In Japan For Relapsing MS
Industry Brief - First Data From The Prostate Cancer Registry Released At ECC 2015
Industry Trend Analysis - Roche's Entry Into Checkpoint Inhibition Market Imminent
Industry Trend Analysis - Developing Successor To Humira Will Be Of Critical Importance To AbbVie
Industry Trend Analysis - Gilead Will Battle To Prevent HCV Market Share Erosion
Industry Trend Analysis - J&J's Long Sighted Approach Could Change HCV Market Dynamics
Industry Trend Analysis - Ocrelizumab Set To Fill Unmet Medical Need In PPMS
Industry Trend Analysis - Amgen And Allergan's Biosimilar Bevacizumab On Target For Blockbuster Status

Table Of Contents

Key Pharma News 05 OCTOBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by GlobalData

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.